Skip to main content

Cerebral Hemorrhage

1
Pipeline Programs
5
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Biocorp
BiocorpFrance - Issoire
1 program
1
Human umbilical cord mesenchymal stem cellsPhase 11 trial
Active Trials
NCT02283879Unknown20Est. Apr 2017
Penumbra
PenumbraALAMEDA, CA
1 program
Artemis + Medical ManagementN/A1 trial
Active Trials
NCT03342664Completed236Est. Sep 2024
Takeda
TakedaTOKYO, Japan
1 program
Care bundle of active managementN/A
Innovation Pharmaceuticals
1 program
Care bundle of active managementN/A1 trial
Active Trials
NCT03209258Completed7,067Est. Nov 2022
IRRAS
IRRASSweden - Stockholm
1 program
IRRAflowN/A1 trial
Active Trials
NCT05118997Recruiting60Est. Sep 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BiocorpHuman umbilical cord mesenchymal stem cells
IRRASIRRAflow
PenumbraArtemis + Medical Management
Innovation PharmaceuticalsCare bundle of active management

Clinical Trials (4)

Total enrollment: 7,383 patients across 4 trials

NCT02283879BiocorpHuman umbilical cord mesenchymal stem cells

Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela

Start: Mar 2015Est. completion: Apr 201720 patients
Phase 1Unknown
NCT05118997IRRASIRRAflow

Active Removal of IntraCerebral Hematoma Via Active Irrigation

Start: Oct 2021Est. completion: Sep 202560 patients
N/ARecruiting
NCT03342664PenumbraArtemis + Medical Management

MIND: Artemis in the Removal of Intracerebral Hemorrhage

Start: Feb 2018Est. completion: Sep 2024236 patients
N/ACompleted
NCT03209258Innovation PharmaceuticalsCare bundle of active management

The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial

Start: Dec 2017Est. completion: Nov 20227,067 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 7,383 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.